IP Library Patent Application 16398210
Patent Application
App. No. 16/398,210

ANAEROBIC ANTIOXIDANT COMPOSITION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/398,210
Abstract

The disclosure relates to compositions, methods and systems for improving levels of free radicals in a body. A composition includes an antioxidant in a reduced state and a deoxygenated water solvent. The composition is such that the antioxidant remains in its reduced state.

Claims (33)

1 . A composition comprising:

an antioxidant in a reduced state; and

a deoxygenated water solvent;

wherein the composition is such that the antioxidant remains in its reduced state.

2 . The composition of claim 1 , wherein the antioxidant is reduced glutathione.

3 . The composition of claim 1 , wherein the composition is microencapsulated.

4 . The composition of claim 1 , wherein the composition is packaged in an airless dispenser configured to maintain an anerobic environment.

5 . The composition of claim 1 , wherein the antioxidant comprises from 5% to 20% by weight of the total composition.

6 . The composition of claim 1 , wherein the composition is microencapsulated in a phospholipid liposome structure.

7 . The composition of claim 1 , wherein the composition is microencapsulated in a gelatin composition.

8 . The composition of claim 1 , wherein the antioxidant is reduced glutathione and wherein the composition comprises from 4 g to 20 g reduced glutathione per 100 mL of the deoxygenated water solvent.

9 . The composition of claim 1 , wherein the antioxidant is reduced glutathione dissolved in the deoxygenated water solvent, and wherein the reduced glutathione comprises a purity from 98% to 99.9% purity in a dry state.

10 . The composition of claim 1 , wherein the composition is prepared for liquid oral consumption.

11 . The composition of claim 1 , wherein the composition is prepared for topical application.

12 . The composition of claim 1 , wherein the composition is prepared for intravenous or intramuscular administration.

13 . The composition of claim 1 , wherein the composition is prepared for inhalant delivery.

14 . A method comprising:

administering a composition to a user, the composition comprising:

an antioxidant in a reduced state; and

a deoxygenated water solvent;

wherein the composition is such that the antioxidant remains in its reduced state.

15 . The method of claim 14 , wherein the antioxidant is reduced glutathione.

16 . The method of claim 14 , wherein the composition is microencapsulated.

17 . The method of claim 14 , wherein the composition is packaged in an airless dispenser configured to maintain an anerobic environment.

18 . The method of claim 14 , wherein the antioxidant comprises from 5% to 20% by weight of the total composition.

19 . The method of claim 14 , wherein the composition is microencapsulated in a phospholipid liposome structure.

20 . The method of claim 14 , wherein the composition is microencapsulated in a gelatin composition.

21 . The method of claim 14 , wherein the antioxidant is reduced glutathione and wherein the composition comprises from 4 g to 20 g reduced glutathione per 100 mL of the deoxygenated water solvent.

22 . The method of claim 14 , wherein the antioxidant is reduced glutathione dissolved in the deoxygenated water solvent, and wherein the reduced glutathione comprises a purity from 98% to 99.9% purity in a dry state.

23 . The method of claim 14 , wherein the composition is administered by way of liquid oral consumption.

24 . The method of claim 14 , wherein the composition is administered by way of topical application.

25 . The method of claim 14 , wherein the composition is administered by way of intravenous or intramuscular administration.

26 . The method of claim 14 , wherein the composition is administered with an inhaler.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2026
From: BLUE SKY INNOVATION, LLC
To: PROFESSIONAL NUTRACEUTICAL DESIGN, LLC
Reel/Frame 073983/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2021
From: PITCHER, STEPHEN N.; PURSER, DANNY C.
To: BLUE SKY INNOVATION, LLC
Reel/Frame 058143/0398 →